Minor cannabinoids: What's behind CBG, CBN, H4CBD & more?

Cannabis is way more than just THC and CBD. Besides the well-known main cannabinoids, the hemp plant contains a bunch of other compounds that show up in much smaller amounts. These substances are called minor cannabinoids or minor CBD / minor cannabinoids. In recent years, interest in these cannabinoids has really taken off because they open up new product categories and help us understand the cannabis plant better.

Here, we explain what minor cannabinoids are, which cannabinoids are included, how they're different, what role new compounds like CBG, CBN, or H4CBD play, and how the legal situation looks—especially in Germany and the EU. Check out this in-depth guide to H4CBD.

What are minor cannabinoids?

Minor cannabinoids are cannabinoids that are only found in very small concentrations in the cannabis plant. Unlike the “major cannabinoids” THC (tetrahydrocannabinol) and CBD (cannabidiol), they usually make up less than one percent of the plant’s total cannabinoid profile.

The term “minor” only refers to the amounts found in the plant, not to how important or relevant these compounds are. In fact, minor cannabinoids play a key role in the overall profile of cannabis products and are increasingly being specifically extracted or synthetically produced.

The hemp plant originally produces cannabinoids in their acidic form. The starting compound is CBGA (cannabigerolic acid), known as the “mother cannabinoid.” Through enzyme processes, CBGA turns into things like THCA, CBDA, and CBCA—and later, through heating or aging, into the well-known neutral cannabinoids.

Why are minor cannabinoids getting more popular?

Minor cannabinoids are getting more attention for a few reasons:

• technological advances in extraction and isolation
• growing demand for THC-free or unique cannabinoid profiles
• legal gray areas around new cannabinoids
• interest in alternative cannabinoids beyond CBD

Plus, minor cannabinoids make new types of products possible, like oils, vapes, or Edibles, which can be very different from each other without being classic THC products.

Overview: Important minor cannabinoids

Here’s a selection of relevant minor cannabinoids. The list isn’t complete, since new cannabinoids are being identified all the time.

1. CBG – Cannabigerol
2. CBN – Cannabinol
3. CBC – Cannabichromene
4. CBGA – Cannabigerolic acid
5. CBDA – Cannabidiolic acid
6. CBL – Cannabicyclol
7. CBT – Cannabicitran
8. Delta-8-THC
9. Delta-10-THC
10. H4CBD – hydrogenated cannabidiol
11. THCv – tetrahydrocannabivarin
12. THCP – tetrahydrocannabiphorol

Not all of these cannabinoids occur naturally. Some are specifically converted from CBD or other cannabinoids, which is especially true for new compounds like H4CBD. Here, we introduce three popular “minor” cannabinoids: CBG, CBN, and H4CBD.

H4CBD – hydrogenated cannabidiol

H4CBD is a chemically modified CBD where hydrogen atoms are added through hydrogenation. Its structure is similar to CBD, but it’s quite different on a molecular level.

What’s special about H4CBD:

• not naturally found in the plant
• more structurally stable than CBD
• part of the “novel cannabinoids” group

H4CBD is mainly used in vapes and concentrates, and its legal status is especially tricky.

CBG – Cannabigerol

CBG is considered the precursor to many other cannabinoids. In mature plants, it’s only found in tiny amounts because it gets converted into other cannabinoids as the plant grows.

• Features of CBG:
• not psychoactive
• structurally stable
• usually obtained from early-harvested plants or isolates

CBG is often found in full-spectrum products or as an isolated ingredient in oils and vapes.

CBN – Cannabinol

CBN is created by the oxidation of THC. The older or more oxidized the plant material, the higher the CBN content can be.

Characteristics of CBN:

• slightly psychoactive (much weaker than THC)
• binds to CB1 and CB2 receptors
• often combined with other cannabinoids

CBN is now often produced on purpose, since natural concentrations in fresh hemp are very low.

Comparing minor cannabinoids

To really compare minor cannabinoids, you need a clear and understandable basis. Since a lot of these compounds have only been in the spotlight for a short time and can be quite different from each other, just listing them isn’t enough. What matters is how a cannabinoid is made, how it’s processed in the body, and what the legal situation is.

Especially in the European market, these factors decide whether a cannabinoid stays relevant long-term or is just available for a short while. A structured comparison helps sort out natural differences and avoid confusion between established and new cannabinoids.

Here are the criteria we’ll look at:

• naturally found in the hemp plant
• possible psychoactive properties
• type of extraction or production method
• legal status in Germany and the EU
• typical product forms and uses

CBG

• naturally found: very low
• psychoactive: no
• production: extraction / isolate
• legal status: usually allowed if THC < 0.3%
• products: oils, Flowers, vapes

CBN

• naturally found: forms through aging
• psychoactive: mild
• production: oxidation or synthesis
• legal status: grey area
• products: oils, vapes, Edibles

H4CBD

• naturally found: no
• psychoactive: debated
• production: chemical hydrogenation
• legal status: unclear / novel food issue
• products: vapes, concentrates

CBC

• naturally found: low
• psychoactive: no
• production: extraction
• legal status: usually unproblematic
• products: full spectrum products

THCv

• naturally found: rare
• psychoactive: yes, short-term
• production: extraction or conversion
• legal status: critical
• products: vapes, Edibles

HHC

• naturally found: traces
• psychoactive: yes
• production: hydrogenation
• legal status: now banned in many countries

Minor cannabinoids vs. major cannabinoids (CBD & THC)

The main difference between major and minor cannabinoids is in their concentration, market presence, legal clarity, and scientific data.

While CBD is thoroughly regulated and researched, minor cannabinoids often exist in legal grey areas. THC is clearly regulated and only allowed to a limited extent in Germany, while many minor cannabinoids are not yet specifically mentioned in the law.

Legal status of minor cannabinoids in Germany & the EU

The legal situation is complex and constantly changing. Basically:

• CBD is legal as long as the THC content is below 0.3% and no medicinal claims are made

• naturally occurring minor cannabinoids are usually allowed if they come from industrial hemp

• semi-synthetic cannabinoids like H4CBD are increasingly subject to bans or novel food regulations

The EU Novel Food Regulation is especially important for orally consumed products. Different legal standards apply to vapes and aroma products, such as chemical or consumer protection law.

Since laws and assessments keep changing, regular legal checks are important.

Final comparison and assessment

Minor cannabinoids significantly expand the range of cannabis products. Substances like CBG or CBC are considered relatively established and less problematic legally, while newer cannabinoids like H4CBD or THCP are much more strictly regulated or already banned.

A direct comparison shows:

• natural minor cannabinoids are more stable in the long run

• synthetically modified cannabinoids carry higher legal risks

• the term minor CBD / minor cannabinoid doesn't describe a effects, but a quantity ratio

For users, this means: Not every new cannabinoid is automatically the same as CBD or THC. Differences in origin, structure, regulation, and product category matter.

Minor cannabinoids will continue to shape the market – but with clear differences in acceptance, availability, and legal certainty.